CompletedPhase 2NCT02938494

Safety and Efficacy of IDP-123 Lotion to Tazorac® Cream, in the Treatment of Acne Vulgaris

Studying Anterior cutaneous nerve entrapment syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Bausch Health Americas, Inc.
Principal Investigator
Anya Loncaric
Valeant Pharmaceuticals
Intervention
IDP-123 Lotion(drug)
Enrollment
210 enrolled
Eligibility
12 years · All sexes
Timeline
20152016

Study locations (16)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02938494 on ClinicalTrials.gov

Other trials for Anterior cutaneous nerve entrapment syndrome

Additional recruiting or active studies for the same condition.

See all trials for Anterior cutaneous nerve entrapment syndrome

← Back to all trials